Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial.
Shi M, Li YY, Xu RN, Meng FP, Yu SJ, Fu JL, Hu JH, Li JX, Wang LF, Jin L, Wang FS.
Shi M, et al.
Hepatol Int. 2021 Dec;15(6):1431-1441. doi: 10.1007/s12072-021-10199-2. Epub 2021 Nov 29.
Hepatol Int. 2021.
PMID: 34843069
Free PMC article.
Clinical Trial.
METHODS: This prospective, open-labeled, randomized controlled study enrolled 219 patients with HBV-related DLC who were divided into control group (n = 111) and umbilical cord-derived MSC (UC-MSC)-treated group (n = 108), then all of them received a follow-up check from O …
METHODS: This prospective, open-labeled, randomized controlled study enrolled 219 patients with HBV-related DLC who were divided into contro …